Page last updated: 2024-11-05

trifluoperazine and Lymphoma, Non-Hodgkin

trifluoperazine has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research Excerpts

ExcerptRelevanceReference
"TA3 mammary carcinoma and MB6A lymphosarcoma cells were added to rat hepatocytes that had been cultured for 24 hours."1.27Adhesion of tumor cells to hepatocytes: different mechanisms for mammary carcinoma compared with lymphosarcoma cells. ( Middelkoop, OP; Roos, E; Van de Pavert, IV, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roos, E1
Middelkoop, OP1
Van de Pavert, IV1

Other Studies

1 other study available for trifluoperazine and Lymphoma, Non-Hodgkin

ArticleYear
Adhesion of tumor cells to hepatocytes: different mechanisms for mammary carcinoma compared with lymphosarcoma cells.
    Journal of the National Cancer Institute, 1984, Volume: 73, Issue:4

    Topics: Animals; Antigens, Surface; Calcimycin; Cell Adhesion; Cell Adhesion Molecules; Cell Line; Cells, Cu

1984